Tony Goodman
Director
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2025-04-01–2026-06-11
-
2017-01-01–2026-06-11
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Operating Officer | $300,000 | $469,967 |
| 2024 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Operating Officer | $298,500 | $376,198 |
| 2023 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Operating Officer | — | $258,932 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.